Fastdosiskombination I randomiserede, kontrollerede forsøg med alt i alt 1471 patienter, var den totale rapporterede forekomst af bivirkninger ved brug af Kinzalkomb (835 patienter) sammenlignelig med forekomsten for telmisartan alene (636 patienter).
Fixed Dose Combination The overall incidence of adverse events reported with Kinzalkomb was comparable to those reported with telmisartan alone in randomised controlled trials involving 1471 patients randomised to receive telmisartan plus hydrochlorothiazide (835) or telmisartan alone (636).